双重二分法审视:女性肺癌与作为慢性病与肺癌共存
本文综述女性肺癌的流行病学变迁及肺癌作为慢性病的理念。历史上肺癌被视为男性疾病,但肺癌也是女性第二大癌症死因,且从不吸烟年轻女性患者增多。早期检测与治疗进步使生存率开始上升,许多患者进入长期带瘤生存状态,需重新审视治疗与照护模式。
要点
- 肺癌是女性第二大癌症死因,不吸烟年轻女性患者群体在增长。
- 近十年早诊与治疗突破使生存率开始上升,患者进入长期带瘤生存。
- 需将肺癌视为慢性病来重新审视治疗与照护模式。
核心结论
- 肺癌的面貌正在改变,女性患者及长期带瘤生存者增多,需以慢性病视角重新审视治疗与照护。
研究设计与样本
- 本文为综述,回顾女性与肺癌的相关方面以及将肺癌作为慢性病共存的概念。
主要发现
- 历史上肺癌常被视为男性疾病,全球男性诊断人数曾为女性两倍以上,主要与吸烟作为首要危险因素有关。
- 肺癌也是女性第二大癌症死因,且从不吸烟的年轻女性诊断人数在增长。
- 近十年早期检测与治疗出现突破性创新,生存率开始上升,许多诊断者进入长期与致命癌症共存的新境况。
临床怎么用
- 呼吸科医生应关注女性肺癌患者中不吸烟年轻群体的增长趋势。
- 对长期带瘤生存患者,需按慢性病模式进行持续照护与随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Lung cancer remains the leading cause of cancer death globally, yet with many recent advances in the diagnosis and treatment of lung cancer, the face of the disease is shifting. Historically, lung cancer is often thought of as a predominantly male disease with more than twice as many men as women being diagnosed worldwide-mostly due to the influence of smoking as the leading risk factor. However, lung cancer is also the second leading cause of cancer death in women and there is a growing population of young women who have never smoked and are being diagnosed. The past decade has seen groundbreaking innovations in both the early detection and treatment of lung cancer. In this new era, survival rates are beginning to increase and many of those diagnosed are finding themselves in a new situation-living long term with a deadly cancer. Here, we review pertinent aspects of women and lung cancer as well as the concept of living with lung cancer as a chronic disease to give a new perspective on the changing face of lung cancer treatment and care.
引用
- Vavalà T, Rigney M, Reale ML, et al. An examination of two dichotomies: Women with lung cancer and living with lung cancer as a chronic disease. Respirology. 2020. PMID: 33124087. doi:10.1111/resp.13965
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。